K Number
K182919

Validate with FDA (Live)

Manufacturer
Date Cleared
2019-01-25

(98 days)

Product Code
Regulation Number
888.3040
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Biofusion Medical SI-Restore® Sacroiliac Joint Fixation System is intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.

Device Description

The SI-Restore® Sacroiliac Joint Fixation System consists of a cannulated titanium (Ti 6AI4V ELI, per ATSM F136) screw with a titanium (Ti 6AI4V ELI, per ATSM F136) washer affixed to the head of the screw for full cortex engagement. The Implant is designed to prevent motion of the sacroiliac (SI) joint. The delivery system uses guide pins for accurate preparation for and placement of the implant.

AI/ML Overview

The provided document is a 510(k) Premarket Notification for the Biofusion Medical SI-Restore® Sacroiliac Joint Fixation System. This document describes a medical device (a bone fixation system), not a software or AI/ML-based device. Therefore, the requested information regarding acceptance criteria and study details for an AI/ML device, such as sample size for test/training sets, data provenance, expert ground truth establishment, adjudication methods, MRMC studies, or standalone algorithm performance, is not applicable to this submission.

The document discusses the following types of performance data for this physical medical device:

  • Static Axial Pull-out and Static Torque to Failure testing (per ASTM F543-13)
  • Static Three-Point Bending and Dynamic Three-Point Bending (per ASTM F1264-14)

These tests confirmed that the device performed as intended and supported the claim of substantial equivalence to a legally marketed predicate device (SI-LOK™ Sacroiliac Joint Fixation System, K112028).

Since the request specifically asks about acceptance criteria and studies for an AI/ML device, and this document pertains to a physical orthopedic implant, I can only state that the requested information is not present in the provided text because the device in question is not an AI/ML product.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG" in blue, and below that, the word "ADMINISTRATION" in blue.

January 25, 2019

Biofusion Medical % Daniel Lanois Principal Consultant SurgOp Support LLC 7512 Lancaster Gate Frisco. Texas 75035

Re: K182919

Trade/Device Name: SI-Restore® Sacroiliac Joint Fixation System Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth or Threaded Metallic Bone Fixation Fastener Regulatory Class: Class II Product Code: OUR Dated: December 21, 2018 Received: December 26, 2018

Dear Daniel Lanois:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

{1}------------------------------------------------

requirements, including, but not limited to: registration and listing (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

Colin O'neill -S

for MNM

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K182919

Device Name

SI-Restore® Sacroiliac Joint Fixation System

Indications for Use (Describe)

The Biofusion Medical SI-Restore® Sacroiliac Joint Fixation System is intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.

Type of Use (Select one or both, as applicable)

☑ Prescription Use (Part 21 CFR 801 Subpart D)
☐ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Date PreparedOctober 18, 2018
ManufacturerBiofusion Medical LLC
Address2503 Cedarview Drive, Austin, Texas 78704
Telephone866-489-0602
Fax866-441-5351
Contact PersonDaniel Lanois
Consultant
AddressSurgOp Support LLC
7512 Lancaster Gate, Frisco, Texas 75035
Telephone678-371-3605
Fax
Emaildaniel@surgopsupport.com
Trade NameSI-Restore® Sacroiliac Joint Fixation System
Common NameBone Screw or Internal Fixation Device
Panel CodeOrthopedic/87
Classification NameSmooth of threaded metallic bone fixation fastener
ClassClass II
Regulation Number21 CFR 888.3040
Product CodeOUR
Name of Predicate Device510(k) #Manufacturer
SI-LOKTM Sacroiliac Joint Fixation SystemK112028Globus Medical
DescriptionThe SI-Restore® Sacroiliac Joint Fixation System consists of a cannulatedtitanium (Ti 6AI4V ELI, per ATSM F136) screw with a titanium (Ti 6AI4V ELI,per ATSM F136) washer affixed to the head of the screw for full cortexengagement. The Implant is designed to prevent motion of the sacroiliac (SI)joint. The delivery system uses guide pins for accurate preparation for andplacement of the implant.
Indications and Intended UseThe Biofusion Medical SI-Restore® Sacroiliac Joint Fixation System isintended for sacroiliac joint fusion for conditions including sacroiliac jointdisruptions and degenerative sacroiliitis.
Technological Characteristics/Substantial EquivalenceDocumentation was provided to demonstrate that the Subject device, issubstantially equivalent to the Predicate. The Subject device is substantiallyequivalent to the Predicate device in intended use, indications for use,materials, technological characteristics, and labeling.
Performance DataStatic Axial Pull-out and Static Torque to Failure testing (per ASTM F543-13)confirmed that the Subject device performed as intended. Also, Static Three-Point Bending and Dynamic Three-Point Bending (per ASTM F1264-14)confirmed that the Subject device performed as intended.
ConclusionBased on the intended use, indications for use, technological characteristics,materials, and comparison to Predicate devices, the Subject device has beenshown to be substantially equivalent to legally marketed Predicate devices.
510(k) Summary (as required by 21 CFR 807.92)
---------------------------------------------------------

§ 888.3040 Smooth or threaded metallic bone fixation fastener.

(a)
Identification. A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.